This page was machine-translated from Korean. For medical decisions, please confirm with the hospital.View in Korean
Conditions treated
- Leukemia
- Lymphoma
- Multiple myeloma
Professor Ko Yeong-il provides personalized treatment for blood cancers such as lymphoma, supported by clinical experience and careful explanations that foster trust.
Hospital information
- Hospital
- Seoul National University Hospital
- Address
- 101 Daehak-ro, Jongno-gu, SeoulOpen in Google Maps
- Appointments
- 1588-5700
Patient rating
Based on 2 patient ratings
- Medical skill4.0
- Expertise4.5
- Explanation4.8
- Kindness4.3
- Sincerity4.3
Education
- 2010–2018 PhD in Medicine, Seoul National University College of Medicine
- 2008–2010 Master of Medicine, Seoul National University College of Medicine
- 1999–2005 Bachelor of Medicine, Seoul National University College of Medicine
Career
- March 2019 Associate Professor, Division of Hematology and Oncology, Seoul National University Hospital
- February 2014–February 2019 Assistant Professor, Division of Hematology and Oncology, Seoul National University Hospital
- May 2013–February 2014 Clinical Fellow, Division of Hematology and Oncology, Seoul National University Hospital
- May 2011–April 2013 Department of Internal Medicine, Gapyung Kkotdongne Nocerian Driel Jae-ae Hospital (Public Health Physician)
- April 2010–April 2011 Department of Internal Medicine, National Sorokdo Hospital (Public Health Physician)
- Title: Non-A type nucleophosmin 1 gene mutation predicts poor clinical outcome in de novo adult acute myeloid leukemia: differential clinical importance of NPM1 mutation according to subtype
- Journal: International Journal of Hematology
- Publication year/month: 2009
- Title: Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway
- Journal: Annals of Hematology
- Publication year/month: 2009
- Title: Class III beta-tubulin, but not ERCC1, is a strong predictive and prognostic marker in locally advanced head and neck squamous cell carcinoma
- Journal: Annals of Oncology
- Publication year/month: 2009
- Title: Low incidence of clinically apparent thromboembolism in Korean patients with multiple myeloma treated with thalidomide.
- Journal: Annals of Hematology
- Publication year/month: 2010
- Title: Expression of class III beta-tubulin correlates with unfavorable survival outcome in patients with resected non-small cell lung cancer
- Journal: Journal of Thoracic Oncology
- Publication year/month: 2010
Academic societies & awards
- September 2021 Korean Society of Genomics / Chair, Planning Committee
- August 2020 Korean Society of Hematology / Secretary, Education and Training Committee
- 2010 Korean Association for Clinical Oncology / Full Member
- 2010 Korean Cancer Study Group / Full Member
- 2010 Korean Cancer Association / Full Member
- 2010 Korean Society for Blood and Marrow Transplantation / Full Member
- 2010 Korean Society of Hematology / Full Member
Frequently asked questions
- What conditions does Ko Yeong-il treat?
- Ko Yeong-il treats Leukemia, Lymphoma and Multiple myeloma.
- Where does Ko Yeong-il see patients?
- Ko Yeong-il sees patients in Hematology and Oncology at Seoul National University Hospital. 101 Daehak-ro, Jongno-gu, Seoul
- How do I book an appointment with Ko Yeong-il?
- Book through the hospital website or by phone (1588-5700). Large university hospitals usually need a referral letter from a local clinic for National Health Insurance to apply.